GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

59 hedge funds and large institutions have $1.12B invested in Global Blood Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$622M
2
+$186M
3
+$38.9M
4
DM
Deerfield Management
New York
+$37.5M
5
PHS
PFM Health Sciences
California
+$32M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.53M
27
$2.05M
28
$1.82M
29
$1.78M
30
$1.74M
31
$1.48M
32
$1.34M
33
$885K
34
$869K
35
$852K
36
$754K
37
$753K
38
$738K
39
$683K
40
$674K
41
$653K
42
$631K
43
$531K
44
$460K
45
$346K
46
$295K
47
$255K
48
$253K
49
$169K
50
$99K
1
2
3